Form 4: GeneDx Holdings Corp. CFO Kevin Feeley Reports Stock Transactions
SEC Form 4 Filing
Kevin Feeley, CFO of GeneDx Holdings Corp., reports the acquisition and disposal of Class A Common Stock related to restricted stock units.
Summary
- On June 1, 2024, Kevin Feeley, the CFO of GeneDx Holdings Corp., acquired 717 shares of Class A Common Stock through the vesting of restricted stock units (RSUs).
- Also on June 1, 2024, 717 shares were sold to cover tax withholding obligations related to the vesting of RSUs.
- On June 3, 2024, Feeley sold 262 shares of Class A Common Stock at a price of $20.55 per share to cover tax obligations.
- Following these transactions, Feeley directly owns 31,291 shares of Class A Common Stock and 6,456 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reflecting standard stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel and their holdings in the company.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 06/01/2024 | Acquisition of 717 shares of Class A Common Stock through RSU vesting and sale of 717 shares to cover tax withholding. |
| 06/03/2024 | Sale of 262 shares of Class A Common Stock at $20.55 per share. |
| 06/04/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.